Cargando…
Biological markers in the etiology of psoriasis: Targeted treatment options
Psoriasis is a common chronic and disabling inflammatory disease that has an enormous physical, functional and psychosocial impact on patients’ quality of life. To date several conventional therapies are available for the treatment of this condition (eg, cyclosporine, methotrexate, retinoids, and ps...
Autores principales: | de Felice, Catia, Marulli, Georgiana Clare, Ardigò, Marco, Berardesca, Enzo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721342/ https://www.ncbi.nlm.nih.gov/pubmed/19707344 |
Ejemplares similares
-
The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy
por: Spandonaro, Federico, et al.
Publicado: (2014) -
Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis
por: Cline, Abigail, et al.
Publicado: (2019) -
Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
por: Hermanns-Lê, Trinh, et al.
Publicado: (2012) -
Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy
por: Agozzino, Marina, et al.
Publicado: (2017) -
Lichen sclerosus: the role of oxidative stress in the pathogenesis of the disease and its possible transformation into carcinoma
por: Paulis, Gianni, et al.
Publicado: (2019)